Pages that link to "Q29619614"
Jump to navigation
Jump to search
The following pages link to Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines (Q29619614):
Displayed 50 items.
- Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation study (Q21090089) (← links)
- Genome-wide association of lipid-lowering response to statins in combined study populations (Q21142620) (← links)
- Low density lipoprotein cholesterol is inversely correlated with abdominal visceral fat area: a magnetic resonance imaging study (Q21245697) (← links)
- A comprehensive review on metabolic syndrome (Q21284500) (← links)
- Investigation of microencapsulated BSH active lactobacillus in the simulated human GI tract (Q21343017) (← links)
- LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management (Q21558651) (← links)
- Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment (Q21561017) (← links)
- The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors (Q21563399) (← links)
- Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba (Q22241658) (← links)
- (Q22241913) (← links)
- Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association (Q22241916) (← links)
- AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update (Q22252415) (← links)
- Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association (Q22306356) (← links)
- Artichoke leaf extract for treating hypercholesterolaemia (Q24185798) (← links)
- Ezetimibe for primary hypercholesterolemia (Q24187681) (← links)
- Preoperative statin therapy for patients undergoing cardiac surgery (Q24187896) (← links)
- Combined therapy with statins and fibrates for people with dyslipidaemia (Q24195172) (← links)
- Screening for peripheral arterial disease (Q24197484) (← links)
- Artichoke leaf extract for treating hypercholesterolaemia (Q24198879) (← links)
- Preoperative statin therapy for patients undergoing cardiac surgery (Q24200475) (← links)
- Colesevelam for type 2 diabetes mellitus (Q24202334) (← links)
- Preoperative statin therapy for patients undergoing cardiac surgery (Q24236372) (← links)
- Colesevelam for type 2 diabetes mellitus (Q24236703) (← links)
- Artichoke leaf extract for treating hypercholesterolaemia (Q24240435) (← links)
- Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis (Q24242787) (← links)
- Combined therapy with statins and fibrates for people with dyslipidaemia (Q24243737) (← links)
- Ezetimibe for primary hypercholesterolemia (Q24244704) (← links)
- Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy (Q24594496) (← links)
- mTOR inhibitors in advanced renal cell carcinoma (Q24612127) (← links)
- Clinical assessment incorporating a personal genome (Q24612653) (← links)
- Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action (Q24613405) (← links)
- Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men (Q24617779) (← links)
- Why patients visit their doctors: assessing the most prevalent conditions in a defined American population (Q24626604) (← links)
- Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk (Q24626884) (← links)
- Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events (Q24629580) (← links)
- Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean? (Q24630160) (← links)
- Are statins diabetogenic? (Q24630205) (← links)
- Standards of medical care in diabetes--2012 (Q24632533) (← links)
- Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response (Q24632568) (← links)
- Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study (Q24633407) (← links)
- Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes (Q24642503) (← links)
- The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials (Q24646234) (← links)
- Influence of patient race on physician prescribing decisions: a randomized on-line experiment (Q24646319) (← links)
- Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial (Q24676024) (← links)
- Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes (Q24685830) (← links)
- The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst (Q24796000) (← links)
- National trends in statin use by coronary heart disease risk category (Q24810059) (← links)
- Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study (Q24814804) (← links)
- Evidence-based prescribing of statins: a developing world perspective (Q25255887) (← links)
- Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings (Q25256963) (← links)